| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-06 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-06 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |